All > Pad

Best Practice Advisory for Peripheral Arterial Disease

Vanderbilt University Medical Center, Nashville, TN
Peripheral Arterial DiseaseBest Practice Advisory - Other
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will focus on understanding how well a Best Practice Advisory for high-intensity statin therapy works in patients with Peripheral Artery Disease.

Eligible Conditions
  • Peripheral Arterial Disease

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
N/A

Similar Trials

1
BQ-123
1
L-Arginine
1
GFH312 80mg

Study Objectives

2 Primary · 1 Secondary · Reporting Duration: Baseline, upon patient discharge through study completion, average of six months

90 days post-discharge
Frequency of High-Intensity Statin Prescription at 90 days post-discharge
Baseline, upon patient discharge through study completion, average of six months
Frequency of High-Intensity Statin Prescription at discharge
Day 90
Frequency of a Composite of Cardiovascular Events

Trial Safety

Phase-Based Safety

1 of 3

Similar Trials

1
BQ-123
1
L-Arginine
2
GFH312 80mg

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

Usual Care
1 of 2
Intervention
1 of 2

Active Control

Experimental Treatment

150 Total Participants · 2 Treatment Groups

Primary Treatment: Best Practice Advisory · No Placebo Group · N/A

Intervention
Other
Experimental Group · 1 Intervention: Best Practice Advisory · Intervention Types: Other
Usual CareNoIntervention Group · 1 Intervention: Usual Care · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, upon patient discharge through study completion, average of six months

Who is running the clinical trial?

Vanderbilt University Medical CenterLead Sponsor
796 Previous Clinical Trials
640,268 Total Patients Enrolled
3 Trials studying Peripheral Arterial Disease
675 Patients Enrolled for Peripheral Arterial Disease
Aaron W Aday, MD, MScPrincipal InvestigatorVUMC Cardiovascular Medicine

Eligibility Criteria

Age 18+ · All Participants · 0 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References

Frequently Asked Questions

Are there any open slots remaining in this study?

"Affirmative. The clinicaltrials.gov repository confirms that this medical trial began recruiting on April 20th 2022, and has since been edited November 8th of the same year. A total of 150 participants are sought from a single site for enrollment." - Anonymous Online Contributor

Unverified Answer

How many candidates has this trial been able to accept thus far?

"Correct. Based on the clinicaltrials.gov database, this ongoing medical trial was first posted on April 20th 2022 and is currently recruiting 150 individuals from a single research site." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top